Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis

Identifieur interne : 001B62 ( Main/Corpus ); précédent : 001B61; suivant : 001B63

Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis

Auteurs : Osamu Yokota

Source :

RBID : ISTEX:7434757C107745856340CED459B977D660ECE2D7

English descriptors

Abstract

Currently, the clinical diagnostic criteria of frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB) are well known to neurologists and psychiatrists. However, the accuracy of the clinical diagnosis of these diseases in autopsy series is not always adequate. For example, FTLD is a syndrome rather than a clinicopathological disease entity that is comprised of various pathological substrates, including Pick's disease, FTLD with microtubule‐associated protein tau gene mutation, FTLD with tau‐negative ubiquitin‐positive inclusions (FTLD‐U), FTLD‐U with progranulin gene mutation, corticobasal degeneration, basophilic inclusion body disease, and neuronal intermediate filament inclusion disease. Whether these underlying pathologies can be identified clinically is one of the greatest interests in neuropathological research. The pathophysiological relationship between Lewy pathology and Alzheimer pathology in DLB is explored with interest because it may be associated with the accuracy of clinical diagnoses. For example, although Lewy pathology may progress from the brain stem nuclei to the cerebral cortex in Parkinson's disease, recent studies have demonstrated that the progression pattern in DLB is not always identical to that in Parkinson's disease. It is also considered that the progression pattern of Lewy pathology correlates with the evolution of clinical symptoms and that the progression pattern of Lewy pathology may be altered when Alzheimer pathology coexists. In the present paper, the clinicopathological features of two demented cases are presented, and some pathological issues associated with the clinical diagnosis of FTLD and DLB are discussed.

Url:
DOI: 10.1111/j.1479-8301.2009.00286.x

Links to Exploration step

ISTEX:7434757C107745856340CED459B977D660ECE2D7

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis</title>
<author>
<name sortKey="Yokota, Osamu" sort="Yokota, Osamu" uniqKey="Yokota O" first="Osamu" last="Yokota">Osamu Yokota</name>
<affiliation>
<mods:affiliation>Department of Neuropathology, Tokyo Institute of Psychiatry, Tokyo, Japan</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7434757C107745856340CED459B977D660ECE2D7</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1111/j.1479-8301.2009.00286.x</idno>
<idno type="url">https://api.istex.fr/document/7434757C107745856340CED459B977D660ECE2D7/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001B62</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis</title>
<author>
<name sortKey="Yokota, Osamu" sort="Yokota, Osamu" uniqKey="Yokota O" first="Osamu" last="Yokota">Osamu Yokota</name>
<affiliation>
<mods:affiliation>Department of Neuropathology, Tokyo Institute of Psychiatry, Tokyo, Japan</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Psychogeriatrics</title>
<idno type="ISSN">1346-3500</idno>
<idno type="eISSN">1479-8301</idno>
<imprint>
<publisher>Blackwell Publishing Asia</publisher>
<pubPlace>Melbourne, Australia</pubPlace>
<date type="published" when="2009-06">2009-06</date>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="91">91</biblScope>
<biblScope unit="page" to="102">102</biblScope>
</imprint>
<idno type="ISSN">1346-3500</idno>
</series>
<idno type="istex">7434757C107745856340CED459B977D660ECE2D7</idno>
<idno type="DOI">10.1111/j.1479-8301.2009.00286.x</idno>
<idno type="ArticleID">PSYG286</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1346-3500</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alzheimer's disease</term>
<term>Lewy body</term>
<term>TDP‐43</term>
<term>neurofilament</term>
<term>tau</term>
<term>ubiquitin</term>
<term>α‐internexin</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Currently, the clinical diagnostic criteria of frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB) are well known to neurologists and psychiatrists. However, the accuracy of the clinical diagnosis of these diseases in autopsy series is not always adequate. For example, FTLD is a syndrome rather than a clinicopathological disease entity that is comprised of various pathological substrates, including Pick's disease, FTLD with microtubule‐associated protein tau gene mutation, FTLD with tau‐negative ubiquitin‐positive inclusions (FTLD‐U), FTLD‐U with progranulin gene mutation, corticobasal degeneration, basophilic inclusion body disease, and neuronal intermediate filament inclusion disease. Whether these underlying pathologies can be identified clinically is one of the greatest interests in neuropathological research. The pathophysiological relationship between Lewy pathology and Alzheimer pathology in DLB is explored with interest because it may be associated with the accuracy of clinical diagnoses. For example, although Lewy pathology may progress from the brain stem nuclei to the cerebral cortex in Parkinson's disease, recent studies have demonstrated that the progression pattern in DLB is not always identical to that in Parkinson's disease. It is also considered that the progression pattern of Lewy pathology correlates with the evolution of clinical symptoms and that the progression pattern of Lewy pathology may be altered when Alzheimer pathology coexists. In the present paper, the clinicopathological features of two demented cases are presented, and some pathological issues associated with the clinical diagnosis of FTLD and DLB are discussed.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Osamu YOKOTA</name>
<affiliations>
<json:string>Department of Neuropathology, Tokyo Institute of Psychiatry, Tokyo, Japan</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Alzheimer's disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>α‐internexin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Lewy body</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>neurofilament</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tau</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>TDP‐43</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>ubiquitin</value>
</json:item>
</subject>
<articleId>
<json:string>PSYG286</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>Currently, the clinical diagnostic criteria of frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB) are well known to neurologists and psychiatrists. However, the accuracy of the clinical diagnosis of these diseases in autopsy series is not always adequate. For example, FTLD is a syndrome rather than a clinicopathological disease entity that is comprised of various pathological substrates, including Pick's disease, FTLD with microtubule‐associated protein tau gene mutation, FTLD with tau‐negative ubiquitin‐positive inclusions (FTLD‐U), FTLD‐U with progranulin gene mutation, corticobasal degeneration, basophilic inclusion body disease, and neuronal intermediate filament inclusion disease. Whether these underlying pathologies can be identified clinically is one of the greatest interests in neuropathological research. The pathophysiological relationship between Lewy pathology and Alzheimer pathology in DLB is explored with interest because it may be associated with the accuracy of clinical diagnoses. For example, although Lewy pathology may progress from the brain stem nuclei to the cerebral cortex in Parkinson's disease, recent studies have demonstrated that the progression pattern in DLB is not always identical to that in Parkinson's disease. It is also considered that the progression pattern of Lewy pathology correlates with the evolution of clinical symptoms and that the progression pattern of Lewy pathology may be altered when Alzheimer pathology coexists. In the present paper, the clinicopathological features of two demented cases are presented, and some pathological issues associated with the clinical diagnosis of FTLD and DLB are discussed.</abstract>
<qualityIndicators>
<score>7.808</score>
<pdfVersion>1.2</pdfVersion>
<pdfPageSize>595.276 x 779.528 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>7</keywordCount>
<abstractCharCount>1697</abstractCharCount>
<pdfWordCount>6752</pdfWordCount>
<pdfCharCount>44029</pdfCharCount>
<pdfPageCount>12</pdfPageCount>
<abstractWordCount>234</abstractWordCount>
</qualityIndicators>
<title>Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis</title>
<genre>
<json:string>review-article</json:string>
</genre>
<host>
<volume>9</volume>
<publisherId>
<json:string>PSYG</json:string>
</publisherId>
<pages>
<total>12</total>
<last>102</last>
<first>91</first>
</pages>
<issn>
<json:string>1346-3500</json:string>
</issn>
<issue>2</issue>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1479-8301</json:string>
</eissn>
<title>Psychogeriatrics</title>
<doi>
<json:string>10.1111/(ISSN)1479-8301</json:string>
</doi>
</host>
<publicationDate>2009</publicationDate>
<copyrightDate>2009</copyrightDate>
<doi>
<json:string>10.1111/j.1479-8301.2009.00286.x</json:string>
</doi>
<id>7434757C107745856340CED459B977D660ECE2D7</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/7434757C107745856340CED459B977D660ECE2D7/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/7434757C107745856340CED459B977D660ECE2D7/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/7434757C107745856340CED459B977D660ECE2D7/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Blackwell Publishing Asia</publisher>
<pubPlace>Melbourne, Australia</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>2009</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis</title>
<author>
<persName>
<forename type="first">Osamu</forename>
<surname>YOKOTA</surname>
</persName>
<affiliation>Department of Neuropathology, Tokyo Institute of Psychiatry, Tokyo, Japan</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Psychogeriatrics</title>
<idno type="pISSN">1346-3500</idno>
<idno type="eISSN">1479-8301</idno>
<idno type="DOI">10.1111/(ISSN)1479-8301</idno>
<imprint>
<publisher>Blackwell Publishing Asia</publisher>
<pubPlace>Melbourne, Australia</pubPlace>
<date type="published" when="2009-06"></date>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="91">91</biblScope>
<biblScope unit="page" to="102">102</biblScope>
</imprint>
</monogr>
<idno type="istex">7434757C107745856340CED459B977D660ECE2D7</idno>
<idno type="DOI">10.1111/j.1479-8301.2009.00286.x</idno>
<idno type="ArticleID">PSYG286</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2009</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Currently, the clinical diagnostic criteria of frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB) are well known to neurologists and psychiatrists. However, the accuracy of the clinical diagnosis of these diseases in autopsy series is not always adequate. For example, FTLD is a syndrome rather than a clinicopathological disease entity that is comprised of various pathological substrates, including Pick's disease, FTLD with microtubule‐associated protein tau gene mutation, FTLD with tau‐negative ubiquitin‐positive inclusions (FTLD‐U), FTLD‐U with progranulin gene mutation, corticobasal degeneration, basophilic inclusion body disease, and neuronal intermediate filament inclusion disease. Whether these underlying pathologies can be identified clinically is one of the greatest interests in neuropathological research. The pathophysiological relationship between Lewy pathology and Alzheimer pathology in DLB is explored with interest because it may be associated with the accuracy of clinical diagnoses. For example, although Lewy pathology may progress from the brain stem nuclei to the cerebral cortex in Parkinson's disease, recent studies have demonstrated that the progression pattern in DLB is not always identical to that in Parkinson's disease. It is also considered that the progression pattern of Lewy pathology correlates with the evolution of clinical symptoms and that the progression pattern of Lewy pathology may be altered when Alzheimer pathology coexists. In the present paper, the clinicopathological features of two demented cases are presented, and some pathological issues associated with the clinical diagnosis of FTLD and DLB are discussed.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>Alzheimer's disease</term>
</item>
<item>
<term>α‐internexin</term>
</item>
<item>
<term>Lewy body</term>
</item>
<item>
<term>neurofilament</term>
</item>
<item>
<term>tau</term>
</item>
<item>
<term>TDP‐43</term>
</item>
<item>
<term>ubiquitin</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2009-06">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/7434757C107745856340CED459B977D660ECE2D7/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Blackwell Publishing Asia</publisherName>
<publisherLoc>Melbourne, Australia</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1479-8301</doi>
<issn type="print">1346-3500</issn>
<issn type="electronic">1479-8301</issn>
<idGroup>
<id type="product" value="PSYG"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup>
<title type="main" sort="PSYCHOGERIATRICS">Psychogeriatrics</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="06002">
<doi origin="wiley">10.1111/psy.2009.9.issue-2</doi>
<numberingGroup>
<numbering type="journalVolume" number="9">9</numbering>
<numbering type="journalIssue" number="2">2</numbering>
</numberingGroup>
<coverDate startDate="2009-06">June 2009</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="reviewArticle" position="9" status="forIssue">
<doi origin="wiley">10.1111/j.1479-8301.2009.00286.x</doi>
<idGroup>
<id type="unit" value="PSYG286"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="12"></count>
</countGroup>
<titleGroup>
<title type="tocHeading1">REVIEW ARTICLES</title>
</titleGroup>
<copyright>© 2009 The Author; Journal compilation © 2009 Japanese Psychogeriatric Society</copyright>
<eventGroup>
<event type="firstOnline" date="2009-07-07"></event>
<event type="publishedOnlineFinalForm" date="2009-07-07"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-04"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-07"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-03"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst" number="91">91</numbering>
<numbering type="pageLast" number="102">102</numbering>
</numberingGroup>
<correspondenceTo>Dr Osamu Yokota MD, PhD, Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2‐5‐1 Shikata‐cho, Okayama 700‐8558, Japan. Email:
<email>oyokota1@yahoo.co.jp</email>
</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:PSYG.PSYG286.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<unparsedEditorialHistory>Received 1 September 2008; accepted 30 November 2008.</unparsedEditorialHistory>
<countGroup>
<count type="figureTotal" number="5"></count>
<count type="tableTotal" number="0"></count>
<count type="formulaTotal" number="0"></count>
<count type="referenceTotal" number="91"></count>
<count type="wordTotal" number="7566"></count>
<count type="linksPubMed" number="0"></count>
<count type="linksCrossRef" number="0"></count>
</countGroup>
<titleGroup>
<title type="main">Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis</title>
<title type="shortAuthors">O. Yokota</title>
<title type="short">Antemortem diagnosis of FTLD and DLB</title>
</titleGroup>
<creators>
<creator creatorRole="author" xml:id="cr1" affiliationRef="#aff-1-1">
<personName>
<givenNames>Osamu</givenNames>
<familyName>YOKOTA</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="aff-1-1" countryCode="JP">
<unparsedAffiliation>Department of Neuropathology, Tokyo Institute of Psychiatry, Tokyo, Japan</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en">
<keyword xml:id="k1">Alzheimer's disease</keyword>
<keyword xml:id="k2">α‐internexin</keyword>
<keyword xml:id="k3">Lewy body</keyword>
<keyword xml:id="k4">neurofilament</keyword>
<keyword xml:id="k5">tau</keyword>
<keyword xml:id="k6">TDP‐43</keyword>
<keyword xml:id="k7">ubiquitin</keyword>
</keywordGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>Currently, the clinical diagnostic criteria of frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB) are well known to neurologists and psychiatrists. However, the accuracy of the clinical diagnosis of these diseases in autopsy series is not always adequate. For example, FTLD is a syndrome rather than a clinicopathological disease entity that is comprised of various pathological substrates, including Pick's disease, FTLD with microtubule‐associated protein tau gene mutation, FTLD with tau‐negative ubiquitin‐positive inclusions (FTLD‐U), FTLD‐U with progranulin gene mutation, corticobasal degeneration, basophilic inclusion body disease, and neuronal intermediate filament inclusion disease. Whether these underlying pathologies can be identified clinically is one of the greatest interests in neuropathological research. The pathophysiological relationship between Lewy pathology and Alzheimer pathology in DLB is explored with interest because it may be associated with the accuracy of clinical diagnoses. For example, although Lewy pathology may progress from the brain stem nuclei to the cerebral cortex in Parkinson's disease, recent studies have demonstrated that the progression pattern in DLB is not always identical to that in Parkinson's disease. It is also considered that the progression pattern of Lewy pathology correlates with the evolution of clinical symptoms and that the progression pattern of Lewy pathology may be altered when Alzheimer pathology coexists. In the present paper, the clinicopathological features of two demented cases are presented, and some pathological issues associated with the clinical diagnosis of FTLD and DLB are discussed.</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup>
<note xml:id="fn1" numbered="no">
<p>This review article was presented by the author in Symposium of the 23rd annual meeting of Japanese Psychogeriatric Society in Kobe, 27–28 June 2008.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Antemortem diagnosis of FTLD and DLB</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis</title>
</titleInfo>
<name type="personal">
<namePart type="given">Osamu</namePart>
<namePart type="family">YOKOTA</namePart>
<affiliation>Department of Neuropathology, Tokyo Institute of Psychiatry, Tokyo, Japan</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="reviewArticle"></genre>
<originInfo>
<publisher>Blackwell Publishing Asia</publisher>
<place>
<placeTerm type="text">Melbourne, Australia</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2009-06</dateIssued>
<edition>Received 1 September 2008; accepted 30 November 2008.</edition>
<copyrightDate encoding="w3cdtf">2009</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="figures">5</extent>
<extent unit="references">91</extent>
<extent unit="words">7566</extent>
</physicalDescription>
<abstract lang="en">Currently, the clinical diagnostic criteria of frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB) are well known to neurologists and psychiatrists. However, the accuracy of the clinical diagnosis of these diseases in autopsy series is not always adequate. For example, FTLD is a syndrome rather than a clinicopathological disease entity that is comprised of various pathological substrates, including Pick's disease, FTLD with microtubule‐associated protein tau gene mutation, FTLD with tau‐negative ubiquitin‐positive inclusions (FTLD‐U), FTLD‐U with progranulin gene mutation, corticobasal degeneration, basophilic inclusion body disease, and neuronal intermediate filament inclusion disease. Whether these underlying pathologies can be identified clinically is one of the greatest interests in neuropathological research. The pathophysiological relationship between Lewy pathology and Alzheimer pathology in DLB is explored with interest because it may be associated with the accuracy of clinical diagnoses. For example, although Lewy pathology may progress from the brain stem nuclei to the cerebral cortex in Parkinson's disease, recent studies have demonstrated that the progression pattern in DLB is not always identical to that in Parkinson's disease. It is also considered that the progression pattern of Lewy pathology correlates with the evolution of clinical symptoms and that the progression pattern of Lewy pathology may be altered when Alzheimer pathology coexists. In the present paper, the clinicopathological features of two demented cases are presented, and some pathological issues associated with the clinical diagnosis of FTLD and DLB are discussed.</abstract>
<subject lang="en">
<genre>Keywords</genre>
<topic>Alzheimer's disease</topic>
<topic>α‐internexin</topic>
<topic>Lewy body</topic>
<topic>neurofilament</topic>
<topic>tau</topic>
<topic>TDP‐43</topic>
<topic>ubiquitin</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Psychogeriatrics</title>
</titleInfo>
<genre type="Journal">journal</genre>
<identifier type="ISSN">1346-3500</identifier>
<identifier type="eISSN">1479-8301</identifier>
<identifier type="DOI">10.1111/(ISSN)1479-8301</identifier>
<identifier type="PublisherID">PSYG</identifier>
<part>
<date>2009</date>
<detail type="volume">
<caption>vol.</caption>
<number>9</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>2</number>
</detail>
<extent unit="pages">
<start>91</start>
<end>102</end>
<total>12</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">7434757C107745856340CED459B977D660ECE2D7</identifier>
<identifier type="DOI">10.1111/j.1479-8301.2009.00286.x</identifier>
<identifier type="ArticleID">PSYG286</identifier>
<accessCondition type="use and reproduction" contentType="copyright">© 2009 The Author; Journal compilation © 2009 Japanese Psychogeriatric Society</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Publishing Asia</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B62 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001B62 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:7434757C107745856340CED459B977D660ECE2D7
   |texte=   Frontotemporal lobar degeneration and dementia with Lewy bodies: Clinicopathological issues associated with antemortem diagnosis
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024